Suni Sreepada is a partner in the mergers & acquisitions group who guides public and private companies, as well as private equity firms, in global transactions. With a particular focus on transactions involving public companies, Suni advises on a broad array of deals, including mergers, acquisitions, joint ventures, divestitures and strategic investments. She also counsels clients on SEC disclosure and stock exchange compliance considerations.
Known for skillfully managing deals that range in size from the middle market to $10 billion-plus, Suni has recently been named a “Top Rising Star” by The Deal, the New York Law Journal and Law360. She advises clients in a wide range of industries, including energy and infrastructure; life sciences; retail and consumer brands; and technology, media and telecommunications.
Prior to joining Ropes & Gray, Suni was a partner in the New York office of another international law firm.
Experience
- Nippon Steel, Japan’s largest steelmaker, in its $14.1 billion pending acquisition of U.S. Steel.
- Summa Equity AB, Olink Holding AB’s largest shareholder, in its $3.1 billion sale to Thermo Fisher Scientific Inc.
- Provention Bio, Inc., in its $2.9 billion sale to Sanofi.
- EQT Private Capital Asia in its $1.1 billion acquisition of PropertyGuru Group Limited.
- GI Partners in several transactions, including:
- its $1.05 billion acquisition of Atlas Technical Consultants, Inc.
- its take-private acquisition of GTY Technology Holdings Inc.
- Ginkgo Bioworks in its $300 million acquisition of Zymergen.
- AlerisLife Inc. in its sale to ABP Acquisition LLC.
- Calpine Corporation in its $17 billion sale to Energy Capital Partners and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board.*
- IFM Investors in its $10.3 billion acquisition of Buckeye Partners, L.P., which transaction was named "Private Equity Deal of the Year (Over $10 billion)" by M&A Advisor (2020).*
- Avast plc in its $9.2 billion sale to NortonLifeLock.*
- A consortium composed of Brookfield Infrastructure and its institutional partners and GIC on the $8.4 billion acquisition of Genesee & Wyoming Inc., which transaction was named "Private Equity Deal of the Year" by IFLR 2020.*
- LifePoint Health, Inc. in its $5.6 billion merger with RCCH HealthCare Partners.*
- Falcon Capital Acquisition Corp. in its $3.9 billion deSPAC business combination with Sharecare Inc.*
- Macquarie Infrastructure Corporation in its $2.685 billion sale of its International-Matex Tank Terminals business to Riverstone Holdings LLC., its $4.475 billion sale of its Atlantic Aviation business to KKR, its sale of its MIC Hawaii business to Argo Infrastructure Partners, LP, and related restructuring transactions.*
- Roark Capital Group and its portfolio company Arby's Restaurant Group, in Arby's $2.9 billion acquisition of Buffalo Wild Wings, Inc., as well as Roark Capital Group and Inspire Brands, Inc., owner of the Arby's and Buffalo Wild Wings restaurant chains, in Inspire Brands' $2.3 billion acquisition of Sonic Corp.*
- Macquarie Infrastructure Partners V in its $2.9 billion acquisition of Cincinnati Bell Inc.*
- Smiths Group plc in the $2.35 billion sale of its medical division to ICU Medical, Inc.*
- Golden Nugget Online Gaming, Inc. in its $1.56 billion sale to DraftKings Inc.*
- Avast Software in its $1.3 billion acquisition of AVG Technologies.*
- Sempra Energy in its $1.275 billion acquisition by Oncor Electric Delivery Company LLC, a subsidiary of Sempra Energy, of InfraREIT, Inc.*
- EchoStar Corporation in the tax-free spin-off and subsequent merger of its broadcast satellite service business with a subsidiary of DISH Network Corp.*
- NeuroDerm Ltd.in its $1.1 billion sale to Mitsubishi Tanabe Pharma Corporation.*
- Zimmer Biomet in its $1.1 billion acquisition of LDR Holding Corporation.*
- Harvest Partners in its partnership with OMERS Private Equity for the $1 billion acquisition of Epiq Systems, Inc., and its combination with Document Technologies Inc.*
- AIXTRON SE in its $750 million sale to Fujian Grand Chip Investment GmbH, a subsidiary of Fujian Grand Chip Investment Fund LP.*
- A global private infrastructure investment company in its $619 million acquisition of Seven Seas Water Corporation, AquaVenture Holdings Inc. and AquaVenture Holdings Curacao N.V. from AI Aqua (Luxembourg) S.a.r.l, a company owned by Advent International Corporation.*
- Lantheus Holdings, Inc. in its $500 million acquisition of Progenics Pharmaceuticals, Inc.*
- The Special Committee of the Board of Directors of Cellular Biomedicine Group, Inc. in its sale to a consortium including certain members of CBMG management, CBMG stockholders and financial sponsors.*
- Enzymotec Ltd. in its $290 million sale to Frutarom Ltd., a flavors and specialty fine ingredients company.*
*Handled prior to joining Ropes & Gray